White Rock Capital Management

White Rock Capital is a Texas-based hedge fund manager with a focus on biotech and gene therapy investments, particularly in early-stage companies with significant commercial potential. The firm’s founder, Tom Barton, has a history of successful investments in the sector, including foundational roles in companies that developed gene therapies and oncology treatments. The firm’s strategy is to identify and invest in the leading science and management teams in biotech, often taking activist roles to influence company direction. White Rock Capital does not develop drugs itself but provides capital and strategic support to companies advancing novel therapies, especially in oncology and synthetic biology.